Goutifade 80 Mg 30 Tablets

Goutifade 80 Mg 30 Tablets

Description:

Goutifade 80 mg 30 tablets is a prescription oral medicine containing febuxostat, used to manage chronic hyperuricaemia in patients with gout where urate crystal deposition has already occurred (such as gouty arthritis or tophus formation). It works by selectively inhibiting xanthine oxidase, an enzyme responsible for uric acid production, thereby lowering serum uric acid levels and helping to prevent recurrent gout attacks and long-term joint damage. Manufactured by Global Napi Pharmaceuticals, Goutifade is intended for adult use under medical supervision as part of a comprehensive gout management plan including diet and lifestyle modifications.

Indications:

• Treatment of chronic hyperuricaemia in conditions where urate deposition has already occurred (e.g., history of gouty arthritis, presence of tophi).
• Long-term management of gout to maintain target serum uric acid levels and reduce the frequency of acute gout attacks.
• Helps relieve and prevent symptoms associated with high uric acid such as joint pain, swelling, redness, and stiffness due to gout.
• Prevention of further urate crystal deposition in joints and soft tissues, supporting protection against progressive joint damage related to gout.

Active Ingredients / Key Components:

• Febuxostat – 80 mg per film-coated tablet.
• Excipients: Other inactive ingredients (tablet core and film coating) are present but specific excipient names and concentrations , please check the product leaflet or the manufacturer’s official website. Please refer to the official package insert for the full excipient list.

Dosage & Administration / How to Use:

• Recommended dose for adults: 1 tablet (80 mg) once daily, or as directed by the prescribing physician.
• Goutifade tablets may be taken with or without food, with a sufficient amount of water.
• Swallow the tablet whole; do not crush, chew, or break unless otherwise advised by your doctor.
• Use regularly at the same time each day to maintain stable uric acid levels and achieve optimal control of gout.
• This medicine is intended for long-term treatment; do not stop taking it without consulting your doctor, even if you are symptom-free.
• In case of a missed dose, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose to make up for a missed tablet.
• Dosage adjustments may be required in certain patients based on clinical response, laboratory parameters, and co-morbid conditions; follow your doctor’s instructions strictly.

Clinical Benefits:

• Effectively lowers elevated serum uric acid levels by inhibiting xanthine oxidase, the key enzyme in uric acid production.
• Helps reduce the frequency and severity of acute gout attacks over time when used consistently.
• Supports prevention of new urate crystal and tophus formation, helping protect joints and soft tissues from long-term damage.
• Contributes to improved joint comfort, reduced pain, and better mobility in patients with chronic gout when combined with appropriate lifestyle measures.

Warnings & Contraindications:

• Use only under medical supervision. Do not use Goutifade if you are allergic (hypersensitive) to febuxostat or any of the other ingredients in the product.
• Contraindicated in patients treated with azathioprine, mercaptopurine, or theophylline unless specifically managed and monitored by a specialist, due to potential serious drug interactions.
• Use with caution in patients with a history of major cardiovascular disease (such as heart attack or stroke); discuss risks and benefits with your doctor.
• Patients with severe renal or hepatic impairment require careful assessment and possible dose adjustment; follow physician guidance.
• Goutifade is not indicated for the treatment of asymptomatic hyperuricaemia (high uric acid without gout symptoms).
• During the initial phase of treatment, gout flares may increase temporarily as uric acid levels change; your doctor may prescribe additional medicines (e.g., NSAIDs or colchicine) for flare prophylaxis.
• Consult your doctor before use if pregnant, planning pregnancy, or breastfeeding; safety in pregnancy and lactation has not been fully established.
• Inform your doctor about all other medicines you are taking, including over-the-counter drugs and supplements, to avoid interactions.
• Regular monitoring of serum uric acid and, when indicated, liver function tests is recommended during therapy.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical evaluation and prescription.
• Keep out of reach of children.

Side Effects:

• Common side effects may include headache, nausea, mild gastrointestinal discomfort (such as abdominal pain or diarrhea), joint pain, or rash.
• Some patients may experience an increase in gout attacks during the early phase of treatment; this usually decreases with continued therapy and prophylactic treatment.
• Less common but potentially serious side effects can include severe skin reactions, allergic reactions (swelling of face, lips, tongue, difficulty breathing), liver function abnormalities, or cardiovascular events.
• Stop taking the medicine and seek immediate medical attention if you develop signs of severe allergic reaction, widespread rash, blistering of the skin, yellowing of the skin or eyes, chest pain, sudden shortness of breath, or sudden weakness on one side of the body.
• If any side effect persists, worsens, or you notice any unusual symptoms, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Do not use after the expiry date printed on the pack. Store at or below the temperature specified on the product packaging, and protect from excessive heat and moisture.

Specifications:

• Form: Film-coated tablets for oral use.
• Strength: 80 mg febuxostat per tablet.
• Pack size: 30 tablets per pack.
• Serving size: 1 tablet once daily, as prescribed.
• Intended use: Adult prescription medicine for chronic gout and hyperuricaemia management.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.